Skip to main content

America Great Health

corporate_fare Company Profile

America Great Health

AAGH·OTC·Life Sciences·CIK 0001098009

America Great Health is a Wyoming corporation that operates in the medical equipment and health products industry. The company, formerly known as Crown Marketing, underwent a change of control on January 19, 2017, when an investor group led by Mike Q. Wang acquired 16,155,746,000 shares of common stock from the former majority shareholder, Jay Hooper. In connection with this change, the company sold one subsidiary for $100 and another in exchange for the cancellation of all payables and accrued expenses. All assets, liabilities, and results of operations up to January 1, 2017, were accounted for as discontinued operations. On March 1, 2017, the company changed its name from Crown Marketing to America Great Health. On March 9, 2017, it formed a wholly owned subsidiary, also named America Great Health, in California. On June 24, 2019, the company registered a wholly owned subsidiary in China, Meizhong Health Industry Development Co., Ltd. This Chinese subsidiary focuses on mergers and acquisitions, investments and financings, and the marketing of medical equipment and health products in China. On June 30, 2020, America Great Health entered into a Cooperation Agreement with Purecell Group, an anti-aging medical institution in Australia, to acquire 51% of Purecell's equity. On April 6, 2021, the company issued 510,000,000 shares of common stock to Purecell's nominated trustee. This acquisition was completed in May 2021 and is accounted for as an equity investment because America Great Health does not have significant control over Purecell's day-to-day operations.

America Great Health (OTC:AAGH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for AAGH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-22, rated 9/10.

Recent high-impact activity:

  • Micro-Cap AAGH Swings to $1.11M Net Income in Q4 2025

Financial Snapshot

Fiscal year ended June 30, 2025
Revenue
$391.74K
Net Income
-$719.12K
Diluted EPS
$0.00
Op. Cash Flow
-$332.86K
Gross Profit
$339.12K
Operating Income
-$382.94K
Cash & Equivalents
$44.06K
Total Debt
$2.82M
Debt / Equity
-0.50×
Net Margin
-183.6%
Shares Outstanding
21.15B sh
Source: 10-K · filed 2026-04-10 · accession 0001185185-26-001339
$0.0002
52-week range · as of 2026-06-22 $0.000001 – $0.018
Market cap
$4.23M
Volume
1M (0.6× avg)
3-mo avg 1.8M
Live data · 2026-10-05 02:48 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AAGH - Latest Insights

AAGH
Jun 22, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.0002
Real-time Price: $0.0002 info
Change: $0 (0%) info
Market Cap: $4.231M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets